Roche Suspends Phase II Mircera Study In Chemo-Induced Anemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm halts recruitment of anemic non-small cell lung cancer patients due to an “imbalance” of deaths across study arms but maintains they are not related to the drug.